IFNB1 and cancer: While 296 diseases and functions classified by IPA were significantly represented in both KD lines and IFN-β treatments with a raw enrichment P-value <0.05 (−log10 P-value >1.3), this list decreased to 88 when cancer categories were excluded (Table S6).